Importance In clinical practice, patients with primary metastatic renal cell carcinoma (mRCC)
have been offered cytoreductive nephrectomy (CN) followed by targeted therapy, but the …

Study Type – Therapy (case series) Level of Evidence 4 OBJECTIVE To evaluate data obtained
from a large, multi‐institutional, contemporary series of patients who underwent radical …

Background Effective adjuvant therapy for patients with resected localised renal cell
carcinoma represents an unmet need, with surveillance being the standard of care. We report …

Purpose : To date no study to our knowledge has compared cancer control outcomes of
segmental ureterectomy relative to nephroureterectomy, which represents the standard of care …

Purpose: Clusterin (CLU) is an antiapoptotic, stress-induced protein conferring treatment
resistance when overexpressed. This study tested custirsen, a CLU inhibitor, in patients with …

OBJECTIVES: To examine the perioperative mortality rates at 90 days (90 dM) after
nephroureterectomy (NU) and to devise a model capable of identifying individuals at an elevated 90 …

OBJECTIVES: The Epstein criteria represent the most widely used scheme for prediction of
clinically insignificant prostate cancer (PCa). However, they were never validated in …

Purpose : Renal tumor biopsies have been proposed as a management alternative to avoid
treatment of benign or low risk small renal masses. However, many urologists are reluctant …

Purpose: We present our series on the safety and long-term oncologic and functional
outcomes of laparoscopic partial nephrectomy using renal artery perfusion for cold ischemia. …

PURPOSE: External-beam radiation therapy (EBRT) may predispose to secondary malignancies
that include bladder cancer (BCa), rectal cancer (RCa), and lung cancer (LCa). We …